Login / Signup
Exploring Heterogeneity in Cost-Effectiveness Using Machine Learning Methods: A Case Study Using the FIRST-ABC Trial.
Zaid Hattab
Edel Doherty
Zia Sadique
Padmanabhan Ramnarayan
Stephen O'Neill
Published in:
Medical care (2024)
The estimated overall INB of HFNC is smaller than the INB for patients with better baseline status suggesting that HFNC can be more cost-effective among less severely ill patients.
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clinical trial
prognostic factors
single cell
study protocol
patient reported outcomes
patient reported